Antonio Ornelas
CEO
LUMABS BV
The startup has developed a bioluminescence-based homogenous immunoassay platform that enables rapid and sensitive quantification of biomolecules in complex human samples. This platform utilizes ratiometric bioluminescent sensors and a mix-and-measure approach to provide accurate results with minimal user intervention.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$370KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a bioluminescence-based homogenous immunoassay platform that enables rapid and sensitive quantification of biomolecules in complex human samples. This platform utilizes ratiometric bioluminescent sensors and a mix-and-measure approach to provide accurate results with minimal user intervention.